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Genetic information 
from discordant sibling pairs 
points to ESRP2 as a candidate 
trans‑acting regulator of the CF 
modifier gene SCNN1B
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Janine Altmüller5, Nina Dalibor5, Mohammad Reza Toliat 5, Sabina Janciauskiene6,7, 
Burkhard Tümmler4,6 & Frauke Stanke4,6*
SCNN1B encodes the beta subunit of the epithelial sodium channel ENaC. Previously, we reported 
an association between SNP markers of SCNN1B gene and disease severity in cystic fibrosis‑affected 
sibling pairs. We hypothesized that factors interacting with the SCNN1B genomic sequence are 
responsible for intrapair discordance. Concordant and discordant pairs differed at six SCNN1B 
markers (Praw = 0.0075, Pcorr = 0.0397 corrected for multiple testing). To identify the factors binding 
to these six SCNN1B SNPs, we performed an electrophoretic mobility shift assay and captured the 
DNA–protein complexes. Based on protein mass spectrometry data, the epithelial splicing regulatory 
protein ESRP2 was identified when using SCNN1B‑derived probes and the ESRP2‑SCNN1B interaction 
was independently confirmed by coimmunoprecipitation assays. We observed an alternative SCNN1B 
transcript and demonstrated in 16HBE14o− cells that levels of this transcript are decreased upon 
ESRP2 silencing by siRNA. Furthermore, we confirmed that mildly and severely affected siblings 
have different ESPR2 genetic backgrounds and that ESRP2 markers are linked to the response of CF 
patients’ nasal epithelium to amiloride, indicating ENaC involvement (Pbest = 0.0131, Pcorr = 0.068 for 
multiple testing). Our findings demonstrate that sibling pairs clinically discordant for CF can be used to 
identify meaningful DNA regulatory elements and interacting factors.
Genetic variation in humans contributes significantly to phenotypic variation. The question of which single 
nucleotide polymorphism (SNP) determines disease outcome and/or severity, has been addressed in more than 
2000 genome-wide association studies (GWAS)1. However, the results have revealed that more than 90% of the 
polymorphisms identified by GWAS do not directly alter the gene’s coding sequence. This has led to the conclu-
sion that clinically relevant variation of the human genome mediates gene regulation, i.e., the transcript expres-
sion level or the composition of transcript  isoforms2. Recent genome and epigenome studies have substantiated 
this  hypothesis3. Enrichment of elements known for covalent modifications of DNA bases or their associated 
 nucleosomes4 among disease- and trait-associated genetic variants determined by GWAS has also been noted.
The gene affected in cystic fibrosis (CF), cystic fibrosis transmembrane conductance regulator (CFTR), 
encodes a chloride- and bicarbonate channel of  epithelia5–7 that localizes with the epithelial sodium channel 
ENaC at the apical membrane of  many8, albeit not  all9, epithelial cells. Both CFTR and ENaC act synergistically 
to regulate salt and fluid transport across the  epithelium8,10, and the SCNN1B gene, encoding the beta subunit 
of ENaC, is a highly plausible modifier gene of CF.
OPEN
1Institute for Community Medicine, Ernst Moritz Arndt University, Greifswald, Germany. 2xValue GmbH, Villich, 
Germany. 3Research Core Unit Proteomics, Hannover Medical School, Hannover, Germany. 4Department of 
Paediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany. 5Cologne 
Center for Genomics, University of Cologne, Cologne, Germany. 6German Center for Lung Research (DZL), 








Scientific Reports |        (2020) 10:22447  | https://doi.org/10.1038/s41598-020-79804-y
www.nature.com/scientificreports/
Previously, we focused on the three genes encoding the subunits of ENaC as candidate genes in the European 
CF twin and sibling  study11. In an association study on extreme phenotypes, anthropometry and lung function 
data were used to select patients whose clinical data fell below the 25th centile (severely affected) or above the 
75th centile (mildly affected) for both clinical  parameters12. Three groups of affected patient pairs were defined 
as follows by a ranking algorithm used to describe the severity of CF: concordant mildly affected sibling pairs, 
concordant severely affected sibling pairs and discordant sibling pairs. Discordant sibling pairs were composed 
of one mildly and one severely affected  sibling12.
When discordant sibling pairs were compared to concordant sibling pairs, one SCNN1B haplotype defined 
by SNPs rs238547–rs152730–rs250563 occurred more frequently among discordant than among concordant 
 siblings11. We concluded that this signal cannot be fully explained by a variant observed within SCNN1B because 
discordant siblings have a dissimilar phenotype by  definition12, and yet these siblings share an SCNN1B intra-
genic  haplotype11. Our working hypothesis relied on the idea that the association signal in SCNN1B delineates 
a functional regulatory element, whereby a DNA-binding protein encoded in trans interacts with this regula-
tory element, stably binding to the haplotype of the regulatory element that is predominant among discordant 
siblings. Hence, the genetic variation of the interaction partner can determine the phenotype causing intrapair 
discordance in affected sibling pairs.
In association studies involving affected patient pairs, interaction between a regulatory element and a DNA-
binding protein may result in a paradoxical situation. The regulatory element is recognized through an INTER-
pair comparison by an association with the phenotype “discordance of sibs”. However, genetic information at 
the regulatory element is shared by both siblings within a pair, which provides an opportunity to identify the 
DNA-binding protein encoded in trans by an INTRApair comparison. If the phenotype is caused by interaction 
of the DNA-binding protein with the regulatory element, mildly and severely affected siblings of discordant pairs 
must carry different genetic information at the locus encoding the DNA-binding protein.
Figure 1.  Mapping of the association signal determining intrapair discordance among F508del-CFTR 
homozygous CF sibling pairs, identification of an alternative SCNN1B transcript and position of SNPs 
analyzed by EMSA-PSeq. (A) Position of SNP and microsatellite markers on the genomic sequence of the 
SCNN1G/SCNN1B region. The position of genetic markers was derived from the genomic sequence on 
NC_000016 (assembly 03-Feb-2014; GRCh38; region 23302270–23381299). Nomenclature of SCNN1B exons 
was derived from Voilley et al.  199559 and Saxena et al.  199860, who have described exon/intron borders and the 
coding sequence for a 640 amino acid SCNN1B protein encoded by 13 exons (NP_000327.2; GI: 124301196; 
CCDS10609.1). The position of intragenic primers and expected sizes of amplicons covering exon 1–5 of 
SCNN1B are based on this coding sequence. SNPs rs5735, rs5723, rs1004749, rs238547, rs152730, rs250536 
and on microsatellite betaENaCGT were previously  typed11 and further 49 SNPs were genotyped for fine-
mapping (this work). (B) Haplotype blocks, informative markers and association signals in the SCNN1B/
SCNN1G region. Markers depicted in red are informative (minimal allele frequency > 0.4) and were used 
to describe haplotype blocks (a measure of linkage disequilibrium D′ > 0.8) and map association signals as 
previously  described13. Briefly, to map association signals, we defined genomic segments by adjacent ancestral 
informative markers that isolate the fragment that carries the causative variant(s)13. p values were generated by 
the software package  FAMHAP55–57. p values refer to the best signal observed for a two-marker-combination 
of the 20-marker-set (Pbest) and the corrected value for multiple testing of 20 markers (Pcorr). Symbols refer 
to: Star: signal obtained by transmission disequilibrium test in the set of 37 sibling pairs families with extreme 
phenotypes (Pbest = 0.00101 for rs2106247–rs4073289; Pcorr = 0.0561 corrected for multiple testing of 20 
informative markers); Filled triangle: association with intrapair discordance (Pbest = 0.0007 for rs2106247–
rs152745; Pcorr = 0.0397 corrected for multiple testing of 20 informative markers) comparing 14 discordant and 
23 concordant patient pairs. Uncorrected raw p values are shown for single markers (+), 2-marker-haplotypes 
of adjacent informative markers (filled circles; genomic segments spanned by two adjacent markers are linked 
by a black line) and 2-marker-haplotypes of non-adjacent markers (open circles). The SCNN1B association 
signal observed for intrapair discordance (filled triangle) was seen on the neighboring segments rs152730–
rs152745 (Praw = 0.0075) and rs152745–rs152740 (Praw = 0.00869). A second independent association signal 
with intrapair discordance in the SCNN1G locus colocalizes with the previously noted survivor effect at 
 SCNN1G11 and was excluded from further analysis because of this confounding factor. (C) SNPs targeted by 
EMSA-PSeq and combinatorial PCR describing an alternative transcript generated by exon-read-through. 
Interaction partners of SNPs rs152730, rs152731 and rs152744, indicated by red star symbols, have been 
characterized by EMSA-PSeq. Equivalent amounts of cDNA from T84 (I), 16HBE14o-(II), CFTE29o-(III) and 
CFBE41o-(IV) or no template (negative control, N) were analyzed by combinatorial PCR with 5 amplicons. 
The grey intronic sequence (amplicon 1, 2, 3) was derived from ESTs BM694355 and BU730506 (see text and 
supplement for details). Intron-spanning primers targeting the SCNN1B reference mRNA (amplicons 4 and 5) 
as well as amplicon 1 targeting the alternative transcript and the 5′ UTR were observed in all cell lines. The size 
of amplified products from all amplicons was in accordance with the expected length. Size markers are loaded 
in lanes indicated by “—” and contain either a 100-bp-ladder or PCR products of 697 bp, 329 bp, 280 bp and 
170 bp as indicated adjacent to the gel. Sanger sequencing of amplicon 1 confirmed the exon3-read-through 
and Sanger sequencing of amplicon 2 products verified its identity derived from a spliced mRNA as it showed a 
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Results
Six SNPs within SCNN1B differ between concordant and discordant CF patient pairs. We pre-
viously reported that intrapair discordance for CF disease severity is associated with three intragenic markers 
spanning SCNN1B from codon 3 to codon 293. To describe the genomic fragment for which concordant and 
discordant pairs carry different genetic information, we analyzed 7 previously typed  markers11 and 49 SNPs gen-
otyped for fine-mapping in the 16p12 region, encompassing the entire SCNN1G/SCNN1B-locus (Fig. 1). Next, 
Table 1.  Haplotype and diplotype distribution observed among concordant and discordant cystic fibrosis 
F508del homozygous sibling pairs for markers rs152730, rs8044970, rs63982, rs152745, rs152740. a Four rare 
haplotypes (Freq. < 0.05) were observed among discordant pairs, 8 rare haplotypes (Freq. < 0.05) were observed 
among concordant pairs. b To identify all genetic variants associated with intrapair discordance on the genomic 
fragment rs12730–rs152740, the entire 8000 bp genomic fragment was compared by Sanger re-sequencing for 
three homozygotes for TTAGA, two homozygotes for GGAAT and one homozygote for GTCAT (see Table 2).






Other  pooleda 0.074 0.087
rs152730–rs8044970–rs63982–rs152745–rs152740 haplotype




GGAAT/GGAAT b 0.000 0.020
GTCAT/GTCAT b 0.000 0.059
Other pooled 0.144 0.193
Table 2.  Variants observed on contrasting haplotypes identified after Sanger re-sequencing of the 8000 bp 
genomic fragment defined by rs152730–rs152740 associated with intrapair discordance. a rs152730–rs8044970–
rs63982–rs152745–rs152740 were used to map the fragment associated with intrapair discordance and define 
the contrasting haplotypes TTAGA (associated with intrapair discordance) and GGAAT as well as GTCAT 










manifestation rs152730a rs62029384 rs8044970a rs8044984 rs80443907 rs152731 rs152732 rs180878 rs152733
TTAGA Discordant T C T T C T C T T
GGAAT Concordant G T G G T C C T T





as well as 
GTCAT?










manifestation rs63982a rs152745a rs8062922 rs152744 rs62029385 rs152743 rs152741 rs57406669 rs152740a
TTAGA Discordant A G C A C G C C A
GGAAT Concordant A A T G T G T G T





as well as 
GTCAT?
No Yes No Yes No No Yes No Yes
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we employed a haplotype-based fine-mapping strategy previously used to identify causative variants within this 
 cohort13. To determine whether concordant and discordant pairs carried the same or different genetic infor-
mation, we employed the software package FAMHAP to construct two-marker haplotypes composed of two 
informative markers. By using this approach, we found a significant difference in two-marker-haplotype dis-
tributions for two adjacent genomic fragments defined by markers rs152730–rs152745 and rs152745–rs152740 
(Praw = 0.0075 and Praw = 0.00869, respectively; corrected for multiple testing of all informative markers at the 
SCNN1G/SCNN1B-locus Pcorr = 0.0397, Fig. 1). We concluded that the variant(s) that determine intrapair dis-
cordance are located on the genomic fragment between rs152730 and rs152740. Based on the allele frequency 
distribution among concordant and discordant pairs, we selected representatives for the contrasting haplotypes 
for Sanger resequencing of the mapped genomic fragment (Table 1). We chose three homozygotes for the hap-
lotype TTAGA, two homozygotes for the haplotype GGAAT and one homozygote for the haplotype GTCAT for 
sequencing of the rs152730–rs152740 genomic fragment on contrasting alleles at markers rs152730–rs8044970–
rs63982–rs152745–rs152740. We used long-range PCR to amplify an 8269 bp and an 8856 bp product encom-
passing the sequence of interest (Table 2). Sanger sequencing was performed using internal primers positioned 
every 500 bp on the forward and reverse strands. Using the software CodonCode Aligner, 476 primary reads 
with a median length of 737 bp were aligned to the reference sequence, assuring coverage of at least 4 reads 
per haplotype at each genomic position. Based on this alignment, we identified 6 SNP positions for carriers 
of the contrasting haplotypes for which concordant and discordant pairs had different genetic information. At 
the six SNPs rs152730–rs152731–rs152745–rs152744–rs152741–rs152740, alleles associated with intrapair con-
cordance carried the haplotype GCA GTT; in contrast, alleles associated with intrapair discordance carried the 
haplotype TTG ACA . None of these six SNPs reside within the coding sequence of SCNN1B. However, accord-
ing to in silico analyses, they possibly alter the secondary structure of the pre-mRNA (SupplTab. 1, SupplTab. 2, 
SupplFig. 1).  
An uncommon alternative SCNN1B transcript generated by intron retention in epithelial cell 
lines. Because none of the six identified SNPs affect the amino acid sequence of the SCNN1B protein, we 
next aimed to determine whether SCNN1B undergoes alternative splicing. Alternative transcripts were inferred 
from mapped expressed sequence tags (ESTs, SupplFig. 2). As a source for polyA + RNA, we used T84 cells, 
which are derived from colon carcinoma, 16HBE14o-cells, which are virus-transformed non-CF respiratory 
epithelial cells, and CFBE41o- and CFTE29o-cells, both of which are immortalized respiratory epithelial cells 
derived from F508del-CFTR homozygous CF patients. Primers for combinatorial reverse-transcription PCR 
were designed to reflect ESTs reported for SCNN1B in the area of interest defined by SNPs rs152730–rs152740 
(SupplFig. 2A). By using primers located in exons 3 and 4 or exons 3 and 5, we detected wild-type SCNN1B 
in all four epithelial cell lines (Fig. 1C). Additionally, we amplified a 280 bp product using one primer located 
within exon 3 and one primer located 100 bp 3′ of the splice site at the end of exon 3 (Fig. 1C and SupplFig. 2). 
We specifically investigated this intronic sequence because it has been reported to be retained in EST clones 
BM694355 and BU730506, which are generated from a cDNA library prepared from retinal pigment epithelium 
of a healthy adult male. Primers designed to detect ESTs AW844136, CV337204 and BX485038 did not amplify 
a product (SupplFig. 2). The 280 bp product, derived from the alternative SCNN1B transcript generated by exon 
read-through, was reliably amplified from T84 derived cDNA even when the RNA was pretreated with DNAse 
(SupplFig 2). Moreover, Sanger sequencing of the alternative product confirmed its identity at the exon 3/intron 
3 border. Hence, the alternative mRNA was generated by an exon read-through event and matched the genomic 
sequence by the base (SupplFig 2E). Furthermore, primers placed upstream in exon 1 encoding the 5′ UTR of 
SCNN1B in combination with a primer placed on the retained intron sequence yielded a product from cDNA 
(Fig. 1C). Conversely, no signal was observed when using a primer located in the downstream exon 5 in combi-
nation with the retained intron sequence (data not shown). To summarize, cancer-derived intestinal epithelial 
cells as well as virus-immortalized respiratory epithelial cells expressed an alternative SCNN1B transcript in 
which intron 3 was partially retained. If translated, this alternative transcript would preserve the reading frame 
at the end of exon 3 and would be translated into a protein that terminates prematurely after an 26 additional 
amino acids derived from the retained intron sequence, producing a severely truncated SCNN1B protein of 221 
amino acids.
The SCNN1B haplotype found in discordant pairs is enriched for predicted transcription factor 
binding sites. We next assumed that an allelic association with a discordant manifestation of CF sever-
ity is mediated by factors that recognize the allele enriched among discordant pairs. To test our hypothesis, 
we assessed whether the 6-marker-haplotype that is associated with intrapair discordance for CF severity, i.e., 
whether TTG ACA at the six SNPs rs152730–rs152731–rs152745–rs152744–rs152741–rs152740 attracts differ-
ent DNA-binding proteins compared to the GCA GTT allele that is observed among concordant sibling pairs. 
To identify potential transcription factor binding sites, we used the tool “Match” (available at http://www.gene-
regul ation .com/)14, which is based on a library of mononucleotide weight matrices from TRANSFAC6.0. The 
settings were restricted to vertebrate transcription factors and limited to minimize false negatives (estimated 
error rate of 10% for training data set). As an input sequence, we used both alleles at each of the six divergent 
SNPs and + /− 20 bp flanking sequences. Next, we compared the list of putative transcription factor binding sites 
between the input sequences derived from haplotypes associated with concordance and discordance and noted 
those predicted to interact with only one of the two contrasting alleles at each SNP. Surprisingly, only 6 binding 
sites were predicted for the haplotype observed among concordant sibling pairs; 21 predicted interactions were 
exclusively related to the six-marker-haplotype associated with intrapair discordance (Fig. 2, SupplTab 3a). Dif-
ferent from concordant sibling pairs, the haplotype observed among discordant sibling pairs had significantly 
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Figure 2.  No. of predicted interaction partners unique to the six-marker-haplotype observed among 
concordant and discordant CF sibling pairs. Using the software Match at http://www.gene-regul ation .com/14, 
binding sites for transcription factors were predicted for the two contrasting haplotypes composed of the 
six SNPs rs152730–rs152731–rs152745–rs152744–rs152741–rs152740. The figure shows the number of 
additional, allele-specific transcription factor binding sites predicted on the haplotype associated with intrapair 
concordance (grey) and for intrapair discordance (red). Please note that six allele-specific binding sites were 
predicted for haplotype GCA GTT while for TTG ACA , associated with discordance, a total of 21 additional 
binding sites for transcription factors are predicted. Binding sites predicted to be shared for both alleles are not 
shown.
Figure 3.  Electrophoretic mobility shift assay and subsequent protein sequencing (EMSA-PSeq). The dsDNA 
probes for SCNN1B SNP rs152731 allele C, SCNN1B SNP rs152731 allele T and the NFkappaB-P65 consensus 
 motif16 were incubated with T84 nuclear extract. After non-denaturing 7% polyacrylamide electrophoresis, the 
samples were transferred by electrotransfer in a denaturing, SDS-containing buffer onto a membrane assembly 
whereby the gel was covered with an uncharged nylon membrane (Hybond C, Amersham), followed by two 
charged nylon membranes (Hybond N+, Amersham). Unbound oligonucleotides were transferred through 
the uncharged membranes and could be visualized on the charged nylon membranes (SupplFig4, SupplFig5). 
Probes derived from rs152731 gave rise to a high molecular weight complex I which differs from complex 
II generated with an NFkappaB-P65 consensus motif. P65, STAT3 and STAT6 were identified in the high 
molecular weight complex II, whereby for this experiment, the position corresponding to the visualized signal 
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more opportunities to interact with DNA-binding proteins (p = 0.048; in comparison to the expectancy value 
derived from 26 binding sites distributed equally between both haplotypes).
Next, we evaluated whether predicted interacting proteins of the SCNN1B haplotype TTG ACA (SupplTab 3a) 
are associated with the response to amiloride upon superfusion of the nasal epithelium. The function of ENaC 
in vivo can be assessed based on the potential difference between the nasal epithelium and the subcutaneous 
 space15. According to the nasal potential difference with the use of amiloride (indicative of ENaC-mediated 
sodium transport), except for GATA2Sat (Praw = 0.0456), none of the genes encoding predicted interaction 
partners showed an association with ENaC function (SupplTab 3b).
Interaction partners of double‑stranded DNA sequences can be captured with an electropho‑
retic mobility shift assay following protein sequencing (EMSA‑PSeq). As our in silico analysis did 
not extend to DNA-binding proteins with unknown binding motifs, we aimed to identify interacting proteins by 
performing a modified electrophoretic mobility shift assay followed by protein sequencing of the DNA–protein 
complex (EMSA-PSeq; see supplement for experimental details). Briefly, we used nuclear extracts derived from 
epithelial cells and biotinylated 35-mer dsDNA probes that centrally carry one of the contrasting alleles of the 
SNPs as bait. To separate the unbound probe from the probe-protein-complexes, we performed native poly-
acrylamide gel electrophoresis, and the probe-protein-complexes were visualized after transfer of the separated 
samples to a membrane. The gel fragment corresponding to the signal generated by the probe-protein-complex 
was excised, and proteins within the excised gel fragment were identified by protein mass spectrometry. We used 
the NFkappaB-P65-consensus  sequence16 for optimization of the experimental setup. Protein mass spectrom-
etry and MASCOT analysis identified several hundred proteins per high-molecular weight complex. To enable 
the recognition of proteins that incidentally comigrate together with the probe/protein complex and/or that 
bind to any DNA unspecifically, and/or are introduced to the sample as contaminants during handling of the 
gel fragment, a set of 25 EMSA-PSeq experiments were performed in parallel for noise filtering (SupplFig 3). In 
the EMSA-PSeq sample obtained with the NFkappaB-P65-consensus probe (Fig. 3), we detected P65 (score 78, 
tagged by three specific peptides) as a unique signal within a total of 25 evaluated EMSA-PSeq data sets. Addi-
tionally, the EMSA-PSeq sample baited with the NFkappaB-P65-consensus probe uniquely attracted STAT3 and 
STAT6, both of which were not observed in any other of the 25 EMSA-PSeq datasets.
Nucleic acid binding proteins attracted by probes of SNPs rs152730, rs152731 and rs152744 
and identified as unique by EMSA‑PSeq. To detect interaction partners of SCNN1B SNPs associated 
with intrapair discordance, we used certain experimental conditions to detect NFkappaB-P65 using a probe with 
a p65 consensus sequence as bait (Fig. 3). Although we varied the conditions for electrophoresis, electrotransfer 
and detection (see supplement for details), we were not able to obtain a reproducible high-molecular-weight 
complex for either allele of rs152745, rs152741 and rs152740. However, high-molecular-weight DNA–protein-
complexes were observed with probes representing the two contrasting alleles at SNPs rs152730, rs152731 and 
rs152744. As described in detail within the Supplemental material, we have filtered the raw data set of 25 EMSA-
PSeq experiments for low-expressed proteins annotated to have nucleic acid binding capabilities and attracted 
to only one SNP (SupplFig 3).
Even when considering the inaccuracy of complex sizes after separation on the native polyacrylamide gel, 
high-molecular-weight complexes were incompatible with the interaction of a single protein found by EMSA-
PSeq (SupplTab 4). Thus, several independent comigrating protein–protein and protein–protein-nucleic acid 
complexes were likely subjected to protein sequencing. Among the proteins identified as specific for the P65 
consensus probe, P65 was one of 11 proteins (Fig. 4, SupplTab 4). Sixteen, five and eight proteins were identified 
uniquely for SNPs rs152730, rs152731 and rs152744, respectively, by EMSA-PSeq and data mining (Fig. 4, Sup-
plTab 4). Since P65 was found with the same experimental and data evaluation strategy used for the data sets for 
the SCNN1B SNPs, we assume that our true-positive protein of interest has been captured as well.
The ESRP2 genetic background is associated with the manifestation of the amiloride‑sensi‑
tive sodium current in the nasal epithelium. To prove or disprove that a protein identified by EMSA-
PSeq can influence ENaC function, we performed a candidate-gene-based association study among CF patients 
in which one of the studied phenotypes addresses ENaC function in the nasal epithelium in vivo17. To select a 
plausible genetic locus based on the list of 29 candidate proteins (Fig. 4, SupplTab 4), we excluded components 
of the spliceosome multiprotein complex. Among the remaining EMSA-PSeq-derived proteins, the epithelial-
specific splicing regulatory protein 2  ESRP218,19 was the most reasonable candidate. First, CF is an epithelial 
disease and ESRP2 is consistent with this  feature20,21. Second, an alternative SCNN1B transcript was observed 
(Fig. 1C, SupplFig 2) and ESRP2 is plausible based on its role in transcript processing.
We found ESRP2 exclusively on probes representing rs152731 whereas ESRP1 was detected on probes derived 
from the three EMSA-PSeq SNPs (Fig. 5). In the association study, the ESRP1 marker ESRP1-Sat1 showed no 
association with the phenotype or severity of CF (Praw > 0.2). In contrast, ESRP2-Sat1 exhibited an association 
signal (Pbest = 0.04) that was confirmed with a second microsatellite and 5 SNPs (Pbest = 0.0131, Pcorr = 0.068 
for multiple testing of 7 markers; Fig. 5) for the manifestation of amiloride-sensitive sodium conductance, a 
hallmark of ENaC function.
The two rs152731 alleles are nonequivalent concerning ESRP2 binding. ESRP2 was detected as a 
factor binding to the C to T SNP rs152731 by EMSA-PSeq (Fig. 4) by using polyacrylamide gels with a separat-
ing distance of 4 cm. To detect ESRP2-rs152731 binding complexes, we employed EMSAs using polyacrylamide 
gels with a separating distance of 20 cm (Fig. 6A,B). To exclude nonspecific binding, signals obtained with an 
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antibody directed against ESRP2 were compared to protein-DNA-complexes probed with IgG (isotype control). 
Signal intensities for rs152731-C were comparable in IgG and anti-ESRP2-Ab lanes. In contrast, signals obtained 
for rs152731-T were stronger with anti-ESRP2-Ab than with IgG. Normalized signal intensities for rs152731-T 
were higher than those for rs152731-C (p = 0.013).
Next, we addressed whether ESRP2 recognizes rs152731 directly. We used a coimmunoprecipitation (co-IP) 
experiment using a biotinylated rs152731 EMSA probe as bait with a raw nuclear extract. After precipitation with 
an anti-biotin-Ab, detection of ESRP2 by Western blotting in co-IP samples verified that all components sufficient 
for ESRP2 to bind rs152731 are present within the nuclear extract and/or the components used for the EMSA 
preceding co-IP (Fig. 6C,D). In three independent co-IP experiments comparing the two contrasting rs152731 
alleles, ESRP2 signals derived from probes with rs152731-T yielded stronger signals than probes for rs152731-C. 
In summary, the results from two different techniques confirmed that rs152731-T binds ESRP2 better than does 
rs152731-C. Thus, the allele rs152731-T associated with intrapair discordance (Tables 1, 2) attracts ESRP2 to a 
greater extent and is more vulnerable to its genetic variations (Fig. 5).
ESRP2 knockdown alters global SCNN1B expression in 16HBE14o‑cells. To determine whether 
ESRP2 influences the transcript species generated from SCNN1B, we downregulated ESRP2 by siRNA in T84 
and 16HBE14o-cells and quantified the wild-type and the alternative transcripts by qPCR (Fig. 7). Silencing of 
ESRP2 in T84 cells resulted in highly variable changes in SCNN1B transcripts. Moreover, the observed changes 
were comparable to those using scrambled control siRNA. In contrast, no systematic effect of scrambled con-
trol siRNA was detected in 16HBE 14o-cells (p = 0.50 for wild-type, p = 0.32 for alternative SCNN1B transcript; 
Wilcoxon signed-rank test). Moreover, the amounts of wild-type and alternative SCNN1B were increased in 
16HBE14o-cells upon treatment with siRNA directed against ESRP2 (p = 0.015 for wild-type; p = 0.054 for alter-
native SCNN1B transcript). Comparison of changes in wild-type and alternative SCNN1B transcript levels 
assessed by paired ΔΔCt levels for both amplicons indicated that downregulation of ESRP2 induced expression 
of functional wild-type SCNN1B in 16HBE14o-cells (p = 0.081, Wilcoxon signed rank test).
The upper respiratory tract is the origin of 16HBE14o-cells while T84 cells are derived from intestinal cells; 
16HBE14o-cells are virus-immortalized and T84 are colon cancer cells. Because ESRP2 plays a prominent role 
in  cancer18,19, it is not surprising that these two cell lines behaved differently in the ESRP2 gene silencing assay. 
Furthermore, the baseline expression of both SCNN1B transcripts was lower in 16HBE14o than in T84 cells. 
Interestingly, T84 cells carry only one, but 16HBE14o-cells carry two of the ESRP2-receptive alleles T–G–A–C at 
markers rs152731–rs152745–rs152744–rs152741. This may explain the observed differences between 16HBE14o 
and T84 cells in response to ESRP2 silencing. Homozygosity for T–G–A–C is associated with intrapair discord-
ance among CF twins and siblings.
Discussion
The design of the European CF twin and sibling study was inspired by Risch and  Zhang22 who proposed that the 
use of sibling pairs with extremely concordant or discordant phenotypes will advance the discovery of quantita-
tive trait loci in  humans22–24. Due to the high power of this approach, it was estimated that the genotyping load 
for studies undertaken with an extreme sib-pair design, selecting for patient pairs who exhibit phenotypes below 
the 30th or above the 70th centile, can be reduced by up to 40-fold22. Based on this strategy for patient recruit-
ment, 37 F508del-CFTR homozygous sibling pairs of 318 cystic fibrosis affected patient pairs were selected for 
the association study by a ranking  algorithm12. The selected sibling pairs were comparable in terms of their birth 
 cohort11. This strategy helped us to minimize the influence of a major nongenetic  confounder25, i.e., complex 
therapeutic management which has improved the life expectancy of CF patients by several decades. Pulmonary 
and gastrointestinal disease manifestations were assessed quantitatively by CF population centiles for the normal-
ized forced expiratory volume in 1 s (FEV1) and by weight as a percentage of predicted weight for height. For 
Figure 4.  Proteins specific for rs152730, rs152731 and 152744 and abundantly present components of 
the spliceosome identified by EMSA-PSeq. Numbers correspond to MASCOT scores obtained for protein 
sequencing (primary data provided in: raw data xls supplement R3) which is a probability score that describes 
– 10LOG10(P), with P being the probability that the detected protein represents a significant match in this data 
set. ESRP2 was captured on rs152731 probes with a MASCOT score of 119 (C-allele, p = 10–12) and 92 (T-allele, 
p = 10–9), respectively. Data is shown for proteins specific for one SNP (top 40 rows), proteins that exhibit partial 
specificity (spliceosomal proteins) and proteins that were unspecifically found in the majority of probe-derived 
samples but were absent from the majority of negative controls (hnRNPs). Proteins specific for one probe or 
one SNP which were identified from the dataset derived for 25 EMSA-PSeq samples based on 1. Their absence 
from empty negative control samples 2. Their absence from EMSA-PSeq samples obtained with probes for 
other analyzed SNPs 3. Their expression levels of less than 200 ppm according to pax-db and 4. Their annotated 
capabilities to interact with nucleic acids (see SupplFig 3 for details). Data on ESRP1 is provided for comparison 
as both, ESRP1 and ESRP2 were interrogated in an association study (see Fig. 5). As many RNA-binding 
proteins were found among the proteins identified as SNP-specific, and as an alternative SCNN1B transcript 
has been observed, EMSA-PSeq data was systematically screened for constituents of the spliceosome. Exp. ppm 
denotes expression values retrieved from the Protein Abundances Across Organisms-database pax-db61 for the 
data set “colon integrated”, except for EYA3, BAZ2B, DIEXF, PRMT6, TLX2, UTP3, LSM3, LSM5, RP9 [Whole 
organism, (PeptideAtlas, Aug 2014)] and TLX2 [Whole organism (Integrated)]. Samples #26, #27 and #28 have 
been derived from denaturing SDS-polyacrylamide gels, hence these lack the multiprotein complexes observed 
in all other samples derived from native polyacrylamide electrophoresis. Details on experimental conditions are 
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these two parameters, we selected sibling pairs with extreme phenotypes in the upper and lower 25%17,26. Our 
selection criteria were in line with recommendations proposed by Risch and  Zhang22, however, these criteria 
resulted in a small study population, thus limiting the power of the genetic association study. Moreover, since our 
study population is of white European descent, a group in which F508del-CFTR is the most common mutation 
causing CF, we cannot be certain that our findings can be applied to other populations.
Risch and Zhang concluded from their simulation studies that “extremely discordant sibling pairs represent 
a powerful design for the association studies of candidate genes”22, and our findings fully support this idea. The 
Figure 5.  Association study on ESRP1 and ESRP2. (A) Position of intragenic microsatellite marker ESRP1Sat 
within ESRP1. ESRP1 was selected as control as this protein was identified at most probes used for EMSA-
PSeq. In other words, no enrichment of ESRP1 with any probe used for EMSA-PSeq has been observed. No 
association of the ESRP1Sat allele distribution with CF disease severity or manifestation of the basic defect 
was seen (Praw > 0.2; data not shown). (B) Five SNPs and two intergenic microsatellite markers were typed 
on ESRP2. Markers on the ESRP2 locus were in strong linkage disequilibrium recognized by D′ values of 
0.884, 0.918, 0.884 and 0.977 on the four segments between two adjacent SNP markers spanning ESRP2. 
(C,D) Analyzing markers in ESRP2, two association signals were observed: intrapair comparison of mildly 
versus severely affected sibling of discordant pairs was skewed (Praw = 0.1092 for ESRPSat2; Praw = 0.104 
for the combination of ESRP2Sat1 and rs8057119; Pcorr = 0.323 corrected for multiple testing of 7 markers, 
data not shown) and an allelic association with the response to superfusion of the nasal epithelium with 
amiloride assessed by nasal potential difference measurement was seen (Pbest; raw = 0.0131; Pcorr = 0.068 
corrected for multiple testing of 7 markers, data shown in (C,D). For this case-reference association study, 
F508del homozygotes with contrasting responses upon superfusion of the nasal epithelium with amiloride 
were compared in their ESRP2 genetic background. Cases were 16 patients with an amiloride response of 
31 mV, references were 15 patients with 21 mV or  less17. Raw p values of single markers are shown as “+” in 
(C), for raw p values obtained for multimarker haplotypes, marker positions are shown as “◯” in (C,D). For 
0.02 > Praw > 0.01, multimarker combinations are displayed in (D).
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use of sibling pairs with extreme clinical phenotypes has been applied  before27,28, and our data support the notion 
that gene–gene interactions mediated by factors encoded in trans of the studied locus can be distinguished in an 
association study when mildly and severely affected siblings of discordant pairs are compared (Fig. 8).
Hence, in this study we identified a haplotype within SCNN1B associated with intrapair discordance in CF 
sibling pairs (Fig. 1, Tables 1, 2). We investigated in silico (Fig. 2) and experimentally (Figs. 3, 4) the occurrence 
of DNA-binding proteins interacting differentially with single or multiple SNPs within the haplotype. We were 
able to recognize ESRP2 as a candidate for validation among nucleic acid binding proteins, which showed an 
association with SCNN1B/ENaC function (Fig. 5). We further employed EMSA and co-IP as two different experi-
mental approaches to support the allele-dependent interaction between rs152731 in SCNN1B and the nucleic 
acid binding protein ESRP2 (Fig. 6). Moreover, we demonstrated that siRNA mediated silencing of ESRP2 in 
respiratory epithelial cells causes an alteration in global SCNN1B expression (Fig. 7). Altogether, our findings 
consistently support the idea that SCNN1B and ESRP2 are interacting partners and that ESRP2 is capable of 
altering the SCNN1B transcript repertoire. It is plausible that this interaction can alter ENaC function and has 
an influence on the manifestation of CF.
Our proof-of-principle study has several limitations. Specifically the findings cannot fully explain whether the 
regulatory element within SCNN1B leads to the alternative SCNN1B transcript, from which a severely truncated, 
221 amino acid SCNN1B may be translated. Similar truncated SCNN1B isoforms of 217 and 306 amino acids 
have been observed in patients with systemic  pseudohypoaldosteronism48. In addition, heterologous expres-
sion of these truncated SCNN1B mutants in Xenopus oocytes showed that they can assemble with wild-type 
alpha- and gamma ENaC  subunits48. These SCNN1B mutants resulted in lower ENaC activity (by 3–7%) than 
the wild-type  protein48. Under physiological conditions, parallel expression of two SCNN1B transcript species, 
one of which yields a truncated SCNN1B isoform upon translation, can reduce SCNN1B function but the extent 
remains unclear.
Using EMSA-Pseq for the identification of DNA-binding proteins has previously been  conceived29–31. To 
examine whether our EMSA conditions allowed the formation of high-molecular-weight multiprotein com-
plexes with coherent DNA–protein-interactions in vivo, we investigated protein-DNA-complexes using an 
NFkappaB-P65-consensus as bait. In line with published  data32–35, this probe attracted NFkappaB-p65 and its 
known interaction partners, such as STAT3 and STAT6. From the EMSA-Pseq of SCNN1B probes, we selected 
ESRP2 as a candidate for further validation experiments. This selection was based on the fact that this protein 
is characteristically expressed in epithelial cells and that similar to other SNP-specific proteins recognized by 
EMSA-PSeq, ESRP2 has been well-characterized as an RNA-binding  protein18,19.
The defining border between RNA- and DNA-binding proteins has recently softened because typical DNA-
binding proteins have become known to target long noncoding RNAs, defining dual-recognition nucleic acid 
binding  proteins36,37. A growing number of nucleic acid binding proteins have been recognized to interact with 
both nucleic acid  species37–44 and genomic  DNA45. The ability to bind to DNA and RNA simultaneously des-
ignates a dual recognition protein capable of shuttling between both nucleic acid types during  transcription38. 
During transcription, DNA and RNA are physically close, and therefore, cotranscriptional processes, such as 
pre-mRNA splicing, can be mediated by putative dual-recognition proteins, such as hnRNP splicing regulatory 
 factors46,47.
Nevertheless, we cannot exclude that SCNN1B may have other important interacting partners in addition to 
ESRP2 that were not discovered in this study. In this work, we analyzed only three of six SNPs by EMSA-PSeq. 
Furthermore, while we filtered our primary protein sequencing data using a positive control (NFkappaB-P65) 
and several technical controls to recognize contamination, we did not incorporate a protein–probe-interaction 
with low binding affinity, which might enable the detection of weak interacting partners. In the future, the reso-
lution of the EMSA-Pseq can be improved by using scrambled probes to control for nonspecific binding and by 
incorporating the false-positives captured in the data evaluation strategy. Moreover, EMSA-PSeq utilizes mass 
spectrometry to identify proteins. In contrast, nucleic acids such as long noncoding RNAs with the potential of 
interacting with the DNA sequence cannot be identified in this experimental setting, and thus, their relevance 
needs to be verified by other methods.
The haplotype associated with intrapair discordance covers a genomic segment of 8 kb, implying that a syner-
gistic relationship of more than one interaction partner is responsible for the selective advantage that underlies 
the maintenance of linkage disequilibrium over such a distance. Thus, it is unlikely that the SCNN1B function 
can be fully understood based on studying single SNPs. Regardless, we are convinced that the methodology 
proposed herein—analysis of clinically discordant sibling pairs in combination with EMSA-PSeq—aids in our 
understanding of how some of the 10,000 SNPs identified by GWAS as being meaningful (www.genom e.gov/
gwast udies . Accessed at 03.02.2015) contribute to the manifestation of phenotypes in humans. As gene–gene 
interactions have been suggested to account for the phenomenon termed “missing heritability”49, the discovery 
of regulatory interactions such as those between ESRP2 and SCNN1B might help to annotate existing GWAS 
data sets that have been performed with sibling  pairs50–52.
Methods
Details on the experimental procedures are provided in the supplement.
Cell culture. Biomaterials were derived from T84 colon cancer cells and immortalized respiratory epithelial 
16HBE14o-, CFBE41o- and CFTE29o-cells.
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RNA preparation. For RNA isolation, cells were cultured in plates, grown to confluency, snap-frozen in 
the gaseous phase of liquid  N2 and stored at − 80 °C. RNA was extracted using QIAamp RNA Blood Mini Kit 
(52,304, Qiagen, Hilden, Germany) and RNase-free DNase Set (79,254, Qiagen, Hilden, Germany).
Oligonucleotides for PCR. Sequences of primers used for genotyping and combinatorial PCR are listed in 
the supplement (SupplTab 5).
Extraction of nuclear proteins. Nuclear extracts were prepared according to published standard 
 methods53 (SupplTab 6). To prevent carryover of the high-salt buffer used for lysis of nuclei, nuclear proteins 
were dialyzed against low-salt HEPES buffer. The completeness of dialysis was verified by measuring the con-
ductivity of the nuclear extract with a needle probe (customized, Technische Forschungswerkstätten of the Han-
nover Medical School). The quality of nuclear proteins was ascertained by verifying the conductivity of the final 
extract after dialysis and by noting the absence of degradation by SDS-electrophoresis followed by Coomassie 
staining.
EMSA‑PSeq. To identify proteins that interact with a specific DNA sequence, we performed an EMSA 
experiment, visualized the shifted band, captured the DNA–protein complexes by excising the corresponding 
region of the polyacrylamide gel and then performed protein mass spectrometry. The composition of the EMSA 
binding buffer was adjusted to reflect the nuclear  milieu54 (SupplTab 7). All experimental details and data analy-
sis methods are provided in the supplement (SupplTab 8, SupplTab 9, SupplFig4, SupplFig5, SupplFig6).
Coimmunoprecipitation. Biotinylated 35-mer double-stranded DNA probes for the rs152731 allele C and 
allele T were incubated with nuclear extract in an EMSA experiment. The DNA–protein-complexes were pre-
cipitated using an anti-biotin antibody and protein G agarose beads. The protein–DNA-complexes were eluted 
from the beads in three consecutive steps, and Western blotting with anti-ESRP2 was used to detect ESRP2 in 
the precipitated protein–DNA-complexes. IgG instead of the anti-biotin antibody served as a negative control in 
all experiments. ESRP2 was identified using a signal from an unpurified nuclear extract developed in parallel in 
each Western blot experiment.
siRNA‑mediated downregulation of ESRP2 in epithelial model cell lines and SCNN1B tran‑
script analysis by real‑time RT‑PCR. siRNA directed against ESRP2 and scrambled control siRNA 
was purchased from GE Healthcare (mixture of four siRNAs, on-target plus pool, GE Healthcare). T84 and 
16HBE14o-cells were transfected for 24 h and 48 h using a protocol supplied by the manufacturer with 10 µl 
of Dharmafect 1 and 100 pmol siRNA in 2 ml of cell culture medium per well of a 6-well plate. Commercially 
Figure 6.  Binding of ESRP2 to rs152731-C and rs152731-T in EMSA and co-immunoprecipitation. (A) EMSA 
experiment using nuclear extract proteins derived from 16HBE14o. Signals marked “HMW” (high molecular 
weight) encompass different entities that can be differentiated by comparing the lane with anti-ESRP2-Ab to 
the control lane using IgG. Presence of ESRP2 in these HMW multi-protein complexes is deduced from the 
increased signal in the presence of an anti-ESRP2-antibody in comparison to the neighboring IgG control lane. 
Nonspec.: nonspecific signal, observed similarly with both, IgG control and anti-ESRP2-Ab. ESRP2/rs152731: 
signal observed predominantly in the presence of anti-ESRP2-Ab. Mixed: protein–DNA-complexes partially 
containing ESRP2 and partially nonspecific. The number of independent experiments is N = 6 whereby nuclear 
extracts were from 16HBE14o (N = 5) and T84 (N = 1). The blot shown is an exemplificative blot out of the 6 
performed replicates (source data is provided with this manuscript). (B) Signals obtained with rs152731 probes 
and an antibody directed against ESRP2 were compared to signals obtained when IgG was used instead of 
the specific antibody. Data from such paired samples are shown from six independent experiments that differ 
concerning nuclear extract and electrophoresis conditions. Signals labelled “ESRP2/rs152731” in Fig. 6A. Could 
be distinguished clearly from the DNA–protein-complex labelled “mixed” in three experiments. Normalized 
data obtained for rs152731-C and rs152731-T probes were compared by Mann–Whitney U test whereby signals 
for high molecular weight complexes observed for rs152731-T were stronger (p = 0.013). (C) 150 µg nuclear 
extract from T84 cells was incubated with 500 nmol dsDNA probes for SCNN1B SNP rs152731 allele C and 
SCNN1B SNP rs152731 allele T in an EMSA experiment of a total reaction volume of 40 µl for 3 h at 37 °C. 
Protein–DNA-complexes were captured with an antibody directed against biotin (ab19221, Abcam, Cambridge, 
UK), or with IgG as a negative control (indicated by “IP”), and precipitated using protein-G-agarose-beads at 
4 °C for 16 h. The supernatant was discarded and proteins were dissociated from agarose beads using Laemmli 
buffer in two elution steps (indicated by “Elu.” 1st and 2nd) of 30 µl each (10 min, 50 °C), loaded on a denaturing 
11% polyacrylamide gel and transferred to a protean supported membrane with 20 µM pore size by tank-blot 
for 50 min at 100 V. ESRP2 immunoreactive bands were visualized with an antibody directed against ESRP2 
(ab113486, Abcam, Cambridge, UK). A lane loaded with nuclear extract only was used as a control to identify 
ESRP2 (predicted molecular weight: 77 kDa). The number of independent experiments is N = 3 whereby nuclear 
extracts were from T84. The blot shown is an exemplificative blot out of the 3 performed replicates (source data 
is provided with this manuscript). (D) In the example shown in (C), ESRP2 signals derived from the probe with 
rs152731 allele C correspond to 85% of the signal observed for rs152731 allele T. Two replicate experiments, not 
shown here, have demonstrated 0% and 65% intensity on the allele rs152731-C, respectively. While the C-to-T-
ratios observed in three co-IP experiments were highly variable, these three experiments consistently indicate 
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available kits were used according to the manufacturer’s instructions. RNA was isolated using the RNA-easy-
mini-kit (Qiagen), transcribed into cDNA with the High-Capacity cDNA Reverse Transcription kit with RNase 
inhibitor (Applied Biosystems) and used as a template for real-time PCR with PowerUp SYBR Green Master Mix 
(Applied Biosystems) to target wild-type and read-through alternative SCNN1B transcripts with the StepOne-
Plus real-time PCR system (ThermoFisherScientific). The housekeeping gene aldolase was amplified from 5 ng 
cDNA with 400 nM forward and reverse primers. SCNN1B transcripts were amplified from 30 ng of cDNA with 
400 nM (read-through alternative transcript) and 700 nM (wild-type transcript) forward and reverse primers, 
respectively. Amplification was carried out using annealing at 60 °C. Threshold cycle (Ct) values were retrieved 
using StepOne-Software (Thermo FisherScientific).
Genetic markers. Except for 7 previously typed  markers11, genetic markers were developed de novo for this 
project. Genotyping was performed by the SNPstream assay (technology by Beckman Coulter, used at Cologne 
Center of Genomics, Cologne, Germany), by microsatellite genotyping using direct blotting  electrophoresis17 or 
by PCR–RFLP (see SupplTab 5a).
Evaluation of genetic data in the association study on European cystic fibrosis twins and sib‑
lings. The work presented here derived data from an association study on European CF twins and  siblings17. 
The study was approved by the ethics committee of Hannover Medical School and written informed consent 
was obtained from all participants or their parental guardians. All methods were performed in accordance with 
relevant guidelines and regulations. The clinical characteristics of the patients have been described in detail 
 elsewhere12,15,17. Briefly, the 12% most informative pairs from the entire sample of 318 CF twin and sibling pairs 
for whom pulmonary function data and weight and height were available in 1996 were selected by a ranking 
 algorithm12. To study genetic modifiers, we aimed to reduce the effect of the disease-causing CFTR gene on the 
disease phenotype, thus deciding to study only one CFTR mutation genotype. F508del-CFTR, present on 70% of 
CF chromosomes from white populations of Central and West-European countries, is the only CFTR mutation 
for which such an approach is feasible. Moreover, patient subsamples were examined to assess the manifestation 
Figure 7.  siRNA-mediated downregulation of ESRP2 affects the SCNN1B transcript spectrum in 16HBE14o-
cells. siRNA directed against ESRP2 (siRNA ESRP2; mix of four siRNAs, on-target plus pool, GE Healthcare) 
or scrambled control (siRNA scr., GE Healthcare); was provided to T84 and 16HBE14o-cells. ESRP2 protein 
expression and SCNN1B mRNA expression levels were compared between cells supplied with the transfection 
agent Dharmafect 1 (Dh.) only versus cells that received Dharmafect and siRNA directed against ESRP2. 
Experiments in both cell lines were conducted from two (T84) or three (16HBE14o) different passages as 
biologically independent replicates whereby in each of these experiments, cell culture plates were treated in 
parallel for the following conditions: growth control (no Dharmafect transfection agent or siRNA; 8 plates), 
transfection agent control (with Dharmafect but without siRNA; 8 plates), treated with siRNA directed against 
ESRP2 (8 plates) and treated with scrambled siRNA (8 plates). Four out of eight plates were harvested at 24 h 
post-transfection and the remaining four plates were analyzed after 48 h post-transfection. Nuclear extracts 
were analyzed for ESRP2 protein expression from one plate in these sets of four (A,B). RNA was isolated from 
the remaining three plates (C). (A) Nuclear extracts derived from 16HBE14o-cells treated with 100 pmol 
siRNA directed against ESRP2 (siRNA ESRP2) or scrambled control (siRNA scr.), transfection control and 
growth control were analyzed for ESRP2 protein by western blot. The intensity of Coomassie-stained high 
molecular weight bands was used as a western blot loading control. Signals for fatty-acid synthase (FASN), 
keratin 8 (KRT8) and βActin are provided as control detections. (B) Reduction of protein expression levels 
of ESRP2 by siRNA directed against ESRP2 was judged from nuclear extracts. All but two sample sets from 
16HBE14o-showed very low or absent ESRP2 protein signals and were excluded from quantitative analysis. (C) 
SCNN1B wild-type (exon3–exon4, see Fig. 1C, amplicon 4) and read-through alternative transcript (see Fig. 1C, 
amplicon 1) were visualized from cDNA derived from control and siRNA-treated cells. Data was evaluated 
based on the threshold cycle Ct provided for an SCNN1B amplicon in comparison to the housekeeping gene 
aldolase from technical duplicates for each qPCR reaction. Independent experiments derived from 12 cell 
culture plates, three each for the conditions growth control (no Dharmafect or siRNA), transfection control 
(Dharmafect only), siRNA ESRP2 and siRNA scr. were included into the analysis if at least two out of three 
samples from all conditions gave valid results for all three amplicons (n = 3 for T84 and n = 3 for 16HBE14o). 
All samples for 16HBE14o 24 h after transfection had to be excluded as SCNN1B transcripts could not be 
detected in the majority of qPCR reactions. ΔCt values were calculated for each sample as Ct[SCNN1B]-
Ct[aldolase]. To compare differential expression between two triplicate sets, ΔΔCt was calculated for all possible 
nine combinations comparing three case and three reference samples. To assess the influence of Dharmafect, 
ΔΔCt[Dharmafect] was calculated as ΔΔCt[Dharmafect] = ΔCt[growth control] – ΔCt[transfection control]. The 
influence of an siRNA ΔΔCt[siRNA ESRP2] and ΔΔCt[siRNA scr.] treatment was calculated as ΔΔCt[siRNA 
ESRP2] = {ΔCt[siRNA ESRP2] – ΔCt[transfection control] – {mean ΔΔCt[Dharmafect]} and ΔΔCt[siRNA 
scr.] = {ΔCt[siRNA scr.] – ΔCt[transfection control]} – {mean ΔΔCt[Dharmafect]}. ΔΔCt[siRNA ESRP2] and 
ΔΔCt[siRNA scr.]. qPCR Data is shown for three independent experiments in each cell line (N = 3) whereby 
values derived from one biological replicate are displayed using the same color in black, grey or white circles, 
respectively. p values were calculated by Wilcoxon signed-rank test to test against the hypothesis that equal 
proportions of samples show an increase or decrease of SCNN1B transcript species upon treatment with siRNA. 
Only unrelated values—i.e. ΔΔCt derived from unshared ΔCt values within biological replicates—were included 
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of the basic defect of impaired ion conductance in the respiratory tissue, as determined in vivo by nasal potential 
difference  measurement15, and in intestinal tissue, as determined ex vivo by intestinal current  measurement15. 
Genetic information obtained from the case and reference populations with contrasting phenotypes was com-
pared using the software package  FAMHAP55, which allows family-based  analysis56,57, accepts data evaluation 
in association studies on unrelated individuals as well as on affected sibling  pairs55 and is adapted to handle 
intrapair comparison of genotype data in sibling  pairs55. Correction for multiple testing at loci typed with more 
than one marker was performed by haplotype  permutation56. For this purpose, the entire data set of cases and 
references was used to estimate haplotype  frequencies55. To ensure a consistent assignment of rare haplotypes 
in small subsamples, the genotype data of 101 families with a total of 171 patients from the European CF twin 
and sibling study were used as a training set in all comparisons. Haplotype, or, in cases of noninformative phase 
or haplotype uncertainty, weighted haplotype explanation lists were assigned to each individual whereby the 
haplotype frequencies of the entire data set were taken into account to compute conditional likelihood  weights55. 
Permutation was performed by randomly assigning the affection status to the individuals in each  replication55. 
For the comparison of case sibling pairs to reference sibling pairs, the affection status was permuted or not with 
an equal chance for both siblings  simultaneously55–57. For all comparisons described herein, the phenotypes and 
sample sizes of the case and reference populations are detailed within the legends, in Figs. 1, 5 and 8 as well as 
in Table 1.
Statistical analyses. The algorithms of Sham and  Curtis58 were used to compare the observed occupancy 
of SCNN1B haplotypes associated with concordance vs discordance with unique transcription factors to the 
expectancy value derived from binding partners distributed equally between both haplotypes.
Figure 8.  Identifying cis and trans regulatory elements in SCNN1B. Concordant mildly (two siblings who 
are shown in green), concordant severely (two siblings who are shown in blue) and discordant siblings (pairs 
composed of one green and one blue colored sib) have been selected from a total of 318 sibling  pairs12 and 
analyzed in a series of case-reference association studies. Cis: The genomic segment rs168748–rs4968000 
determines SCNN1B functionality directly: the observed interpair and matching intrapair association with 
CF disease severity can be explained by the SCNN1B variants in cis (data not shown). Trans: To explain 
the association with the discordant phenotype, variants at SCNN1B genomic segment rs152730–rs152740 
require an interacting partner encoded in trans to SCNN1B. The genetic variation at ESRP2 contributes to the 
manifestation of SCNN1B functionality. In this model, binding sites for DNA interacting partners are shown 
as a triangular groove (for interaction partners shaped as a triangle) and as a square groove (for interaction 
partners shaped as a square). In the context of this work, ESRP2 is represented by a square and fits into its 
binding side at the SCNN1B locus. As a consequence, the phenotype of a sib within a discordant pair is 
shaped by the interaction of ESRP2 and SCNN1B: the allele rs152731-T, associated with intrapair discordance 
(Tables 1,2), is more vulnerable to ESRP2 (Fig. 6) and its genetic variations (Fig. 5). Functionally divergent 
ESRP2 alleles, visualized as green and blue squares, thus determine the phenotype of carriers with ESRP2-
receptive SCNN1B alleles that are shown with a square groove. These ESRP2-receptive SCNN1B alleles include 
rs152731-T and are overrepresented among discordant, but rare among concordant pairs. The five displayed 
association signals correspond to: SCNN1B, rs168748–rs4968000, Praw = 0.01522; Pcorr = 0.0528: interpair 
comparison of allele distribution between 11 concordant mildly and 10 concordant severely affected sibling 
pairs (data not shown). SCNN1B, rs168748–rs4968000, Praw = 0.03371; Pcorr = 0.05: intrapair comparison of 
allele distribution between mildly affected siblings and severely affected siblings from discordant pairs (data not 
shown). SCNN1B, rs152730–rs152740, Praw = 0.0075; Pcorr = 0.0397: interpair comparison of allele distribution 
between 14 discordant sibling pairs and 21 concordant sibling pairs (see Fig. 1B). ESRP2, rs8059575–
rs13339471, Praw = 0.0131; Pcorr = 0.068: comparison of allele distribution of unrelated patients stratified for 
the response of the nasal epithelium upon superfusion with amiloride assessed by nasal potential difference 
measurement (see Fig. 5). ESRP2, rs8059575–rs13339471, Praw = 0.104; Pcorr = 0.323: intrapair comparison of 
allele distribution between mildly affected siblings and severely affected siblings from discordant pairs.
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The EMSA band intensity between rs152731-C and rs152731-T probes was compared using a Mann–Whit-
ney-U-Test in technically (electrophoresis) and biologically (cell culture and preparation of nuclear extract) 
independent experiments.
Changes in the expression levels of SCNN1B transcripts were judged from threshold cycle Ct values obtained 
by qPCR using the ΔΔCt method comparing siRNA or treated cells to untreated controls. To test against the 
hypothesis that no change in the SCNN1B transcript was observed, the Wilcoxon signed rank test was used to 
assess whether or not equal proportions of samples showed an increase or decrease in SCNN1B transcript species 
upon treatment with siRNA. For this analysis, technically (qPCR) and biologically (cell culture and experimental 
intervention) independent Ct values were used. For statistical analysis, ΔΔCt values derived from independent 
siRNA-treated or control samples were used.
Data availability
Supplemental Information is provided with this manuscript. Primary data will be shared with interested parties 
upon reasonable request.
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